Volume 5, Number 2—April 1999
Dispatch
Evaluating Diagnosis and Treatment of Oral and Esophageal Candidiasis in Ugandan AIDS Patients
Table
Characteristics of patients participat- ing in the study
| No. | Mean age (yr) (S.D.) | Sex M/F | |
|---|---|---|---|
| Oral candidiasis | 85 | 24.0 (6.7) | 32 / 53 |
| Esophageal symptomsa | 40 | 17 / 23 | |
| Nystatin group | 20 | 23.9 (6.1) | 7 / 13 |
| Miconazole group | 20 | 23.7 (6.6) | 8 / 12 |
| Esophageal candidiasis | 77 | 23.7 (6.4) | 27 / 50 |
| Nystatin group | 37 | 24.2 (6.5) | 12 / 22 |
| Miconazole group | 40 | 23.4 (6.1) | 15 / 28 |
aEsophageal symptoms are any of the following: odinophagia, dysphagia, retrosternal burning pain.
